$1.36
-0.04[-2.86%]
At close: May 16
$1.36
0[0.00%]
After Hours: 7:09AM EDT
IO Biotech
(NASDAQ:IOBT)IO Biotech Stock (NASDAQ:IOBT), Analyst Ratings, Price Targets, Predictions
IO Biotech Inc has a consensus price target of $9.8, established from looking at the 12 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and Piper Sandler on May 15, 2024, March 6, 2024, and September 28, 2023. With an average price target of $10 between HC Wainwright & Co., HC Wainwright & Co., and Piper Sandler, there's an implied 624.64% upside for IO Biotech Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Piper Sandler
Morgan Stanley
Cowen & Co.
Jefferies
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for IO Biotech
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/15/2024 | Buy Now | 769.57% | HC Wainwright & Co. | Emily Bodnar | $8 → $12 | Maintains | Buy | Get Alert |
| 03/06/2024 | Buy Now | 479.71% | HC Wainwright & Co. | Emily Bodnar | → $8 | Reiterates | Buy → Buy | Get Alert |
| 09/28/2023 | Buy Now | 624.64% | Piper Sandler | Christopher Raymond | → $10 | Initiates | → Overweight | Get Alert |
| 09/13/2023 | Buy Now | 479.71% | HC Wainwright & Co. | Emily Bodnar | → $8 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2023 | Buy Now | 407.25% | Morgan Stanley | Matthew Harrison | $11 → $7 | Maintains | Overweight | Get Alert |
| 08/11/2023 | Buy Now | 479.71% | HC Wainwright & Co. | Emily Bodnar | $11 → $8 | Reiterates | Buy → Buy | Get Alert |
| 03/15/2023 | Buy Now | 624.64% | HC Wainwright & Co. | Emily Bodnar | → $10 | Reiterates | → Buy | Get Alert |
| 01/24/2023 | Buy Now | 697.1% | Morgan Stanley | Matthew Harrison | $15 → $11 | Maintains | Overweight | Get Alert |
| 11/21/2022 | Buy Now | 624.64% | HC Wainwright & Co. | Emily Bodnar | → $10 | Initiates | → Buy | Get Alert |
| 11/30/2021 | Buy Now | 1421.74% | Morgan Stanley | Matthew Harrison | — | Initiates | → Overweight | Get Alert |
| 11/30/2021 | Buy Now | — | Cowen & Co. | Yaron Werber | — | Initiates | → Outperform | Get Alert |
| 11/30/2021 | Buy Now | 1349.28% | Jefferies | Chris Howerton | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for IO Biotech (IOBT)?
The latest price target for IO Biotech (NASDAQ: IOBT) was reported by HC Wainwright & Co. on May 15, 2024. The analyst firm set a price target for $12.00 expecting IOBT to rise to within 12 months (a possible 782.35% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for IO Biotech (IOBT)?
The latest analyst rating for IO Biotech (NASDAQ: IOBT) was provided by HC Wainwright & Co., and IO Biotech maintained their buy rating.
When was the last upgrade for IO Biotech (IOBT)?
There is no last upgrade for IO Biotech.
When was the last downgrade for IO Biotech (IOBT)?
There is no last downgrade for IO Biotech.
When is the next analyst rating going to be posted or updated for IO Biotech (IOBT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IO Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IO Biotech was filed on May 15, 2024 so you should expect the next rating to be made available sometime around May 15, 2025.
Is the Analyst Rating IO Biotech (IOBT) correct?
While ratings are subjective and will change, the latest IO Biotech (IOBT) rating was a maintained with a price target of $8.00 to $12.00. The current price IO Biotech (IOBT) is trading at is $1.36, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.